baber/WOPTO huggingface dataset:
Patent WO-2023023688-A1 (WO)
Title: Over-fill protection apparatus
Inventor: GREGORY JOHN CHARLES
IPC: F16K31/22
Filed: 2021-08-24
Abstract: An apparatus (10) for filling a tank (12) with a fluid such as liquid fuel and water. The apparatus (10) generally includes a fill assembly (14) and a float assembly (16) extending from the fill assembly (14). The fill assembly (14) is adapted to allow a fluid to enter the tank (12) in an open or filling condition and the float assembly (16) functions to move and maintain the fill assembly (14) in a closed or shut-off condition when a fluid level in the tank reaches a predetermined level. This assists to prevent over-filling of the tank and associated issues such as tank over pressurisation and spillage.
Patent WO-2022115901-A1 (WO)
Title: Systems, methods and apparatus for producing an electrolysis gas, hydrogen gas, a hydrogen storage and delivery system and storage cannister
Inventor: SPIROS SPIRO
IPC: C25B11/02
Filed: 2021-11-29
Abstract: Described herein is an electrolysis cell apparatus (2000) comprising an outer enclosure (100) for containing an electrolyte solution, the outer enclosure (100) has a first end (100A), a second end (100B) and an intermediate enclosure section (100M) located between the first and second end (100A), (100B) a plurality of electrolysis cell plates (80) forming at least one electrolysis region in which electrolysis occurs, housed within the outer enclosure (100) and at least partially immersed in an electrolyte solution; and a cell plate enclosure (8000) disposed within the outer enclosure (100) that at least partially encloses the plurality of electrolysis cell plates (80), wherein the cell plate enclosure (8000) is adapted to concentrate electrolyte ions in close proximity to the plurality of electrolysis cell plates (80) in use.
Patent AU-2021201537-A1 (AU)
Title: Methods of increasing crop yield under abiotic stress
Inventor: PENNELL ROGER I
IPC: A01H5/00
Filed: 2021-03-10
Abstract: Methods and materials for increasing abiotic stress tolerance in plants are disclosed. For example, nucleic 
acids encoding abiotic stress tolerance-increasing polypeptides are disclosed as well as methods for using 
such nucleic acids to transform plant cells. Also disclosed are plants having increased tolerance to abiotic 
stress and methods of increasing plant yield under abiotic stress conditions.
Patent AU-2021201705-A1 (AU)
Title: Ezh2 inhibitors for treating lymphoma
Inventor: KEILHACK HEIKE
IPC: C07D407/12
Filed: 2021-03-18
Abstract: The present disclosure relates to compositions comprising inhibitors of human histone 
methyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer 
agents such as prednisone, and methods of combination therapy for administering to subjects 
in need thereof for the treatment of cancer. See Figs. 1A and 1B.
WO 2016/201328 PCT/US2016/037024 
1/6 
0) ui 
>~ 
00 
CNJ 
00 
V e ( )"") EV-d 
4-11 
N0 
4-J) 
0 
C) C C) ) C) C) Cell 
IIN 
L/ABG(vn) 0'0 RJi79-Zd ]
Patent AU-2021202047-A1 (AU)
Title: Improved system and method for timekeeping entry and work in progress reports
Inventor: SHAABAN AHMED FAROUK
IPC: G07C1/00
Filed: 2021-04-01
Abstract: A computer system configured to process time-entry data from a plurality of 
computer devices, the computer system including a database, and an application server 
including a processing device and a non-transitory storage medium for storing instructions 
that, when executed by the processing device, cause the processing device to receive the 
time-entry data from the plurality of computer devices, Store the time-entry data in the 
database, analyse the time-entry data in the database for errors in real time according to a 
predetermined rules, the predetermined rules including a rule that prevents the time-entry 
data from exceeding a predetermined number of hours, automatically overwrite the time
entry data with corrected time entry data when an error is detected according to the 
predetermined rules, and create a work-in-progress report in real time using the corrected 
time entry data.  
39
1/8 
Record Time System -10 
Date, Timekeeper, Client, Matter, Phase, Wk Locatn, 
Law Type, Hours, Activity, Task, Flat Fee Detailed Description 
14 12 
Create Comment or Flag 
System Order Flag 16 
18 
Transfer to Master Data 
20 Local Data Global Data 2 
Confidentiality 
Excessive Billing 26 
28 
Under Billing 
Late Billing 30 
32 
Audit Trail 
WIP Sheets 34 
Figure 1
Patent AU-2021205092-A1 (AU)
Title: Noise suppression
Inventor: XIAO LEI
IPC: E04B1/98
Filed: 2021-07-15
Abstract: P1781AUOO 
ABSTRACT 
A noise suppressor 1 for a stud wall SW. The stud wall comprises studs S and a 
nogging strip NS. The studs have fronts F. Each respective stud of the studs has a 
respective front of the fronts. The fronts are mutually aligned. The nogging strip 
5 may be fastened to the fronts. The noise suppressor comprises a spacing portion 
3 (to space a respective front of a respective stud from the nogging strip) and 
projections 5 projecting rearwardly to sit on either side of the respective stud.
212 
5 
FIGURE 3 
11 
13 
15 17 
FIGURE 4
Patent AU-2021218164-A1 (AU)
Title: Jack stand with integrated load sensing means
Inventor: MOBBS BRIAN
IPC: G01G19/12
Filed: 2021-08-19
Abstract: A jack stand for a towable apparatus comprises a shank with an upper portion and a 
lower portion that has a ground-engaging foot. A spindle is received threadedly by 
the lower portion such that rotating the spindle causes relative vertical translational 
movement between the upper and lower portion. The jack stand comprises a handle 
to rotate the spindle and a thrust bearing to support the upper portion relative to the 
spindle. A load cell is disposed above the thrust bearing that comprises first and 
second annular members spaced-apart by a connection member and an elongate 
passage that receives the spindle. A downwards force acting on the load cell by the 
upper portion causes the first annular member to undergo strain and the load cell to 
generate a signal in response to the strain. Based on the signal, a processor 
calculates and displays a weight value on a display device.
1/7 
26 
32 10 
3 0 16
.-----2 64 2 
1-124 
14 
20 
FIG. 1
Patent AU-2021221433-A1 (AU)
Title: Levelling ramp assembly
Inventor: ROBERTS CHRISTOPER
IPC: B66F7/24
Filed: 2021-08-23
Abstract: A levelling ramp assembly comprising: 
a ramp for supporting a wheel; the ramp having a ramp face with one or more 
ramp attachment elements located on the ramp face; 
at least one chock for engaging a wheel whilst on the ramp; the chock having 
a chock face with one or more chock attachment elements located on the chock face; 
wherein the ramp attachment elements and chock attachment elements 
engage to hold the ramp and the chock together.
1/19 
NC
Patent AU-2021221614-A1 (AU)
Title: Thermal medical device
Inventor: ANDREWS SALLY-ANN
IPC: A61F7/00
Filed: 2021-08-25
Abstract: A thermal medical device comprising: 
an inner body having one or more pieces, each piece having one or more 
anatomical pockets, one or more of the anatomical pockets being filled with thermal 
storage media; and 
an outer cover attached to and covering the inner body.  
20
14/14 
110 1010 10 
110 
10 
FIG1310 
FIG. 23
Patent AU-2021226819-A1 (AU)
Title: Medical system and method of sterility testing the medical system
Inventor: LIST HANS
IPC: A61B5/00
Filed: 2021-02-23
Abstract: The invention discloses a medical system (144). The medical system (144) comprises: i) a housing (146); ii) a preassembled functional module (110) received in the housing (146), the preassembled functional module (110) comprising a. an analyte sensor (112) for detecting at least one analyte in a body fluid of a user; b. an electronics unit (120) electrically connected to the analyte sensor (112); and c. an insertion component (114) for inserting the analyte sensor (112) into a body tissue of the user; and iii) at least one removable protective cap (148) connected to the housing (146), covering the preassembled functional module (110), wherein the preassembled functional module (110) further comprises at least one sterility cap (116), which at least partially surrounds the insertion component (114), wherein the at least one sterility cap (116) is at least partially surrounded by the protective cap (148), wherein the sterility cap (116) comprises at least one sterility testing access (140), the sterility testing access (140) comprising at least one of a septum (142) and a multiple-step sealing (162). Further, methods of providing the medical system (144) and of sterility testing of the medical system (144) are disclosed.
Patent AU-2021231217-A1 (AU)
Title: Uv-Vis radiation curable security inks
Inventor: VEYA PATRICK
IPC: C09D11/037
Filed: 2021-03-03
Abstract: The present invention relates to the field of security inks suitable for printing security features on substrates, in particular on security documents or articles as well as security features made from said security inks, and security documents comprising a security feature made from said security inks. In particular, the invention provides UV-Vis radiation cation ically curable security inks and UV-Vis radiation curable hybrid security inks comprising an ink vehicle and pigments comprising a flake-shaped non- metallic or metallic substrate comprising one or more at least partial coating layers, an at least partial surface treatment layer made of one or more surface modifiers based on perfluoropolyethers.
Patent AU-2021231548-A1 (AU)
Title: Wheel
Inventor: JOHANNISSON WILHELM
IPC: B60B9/26
Filed: 2021-03-03
Abstract: A wheel for MHE (material handling equipment) comprising: a hub; a rim; and spokes, wherein the spokes supportively connect the rim to the hub, wherein the spokes are arranged in a network and least some of the spokes are non-radial, and wherein at least a portion of the spokes are made from a compliant material relative to the material of the rim and or the hub.
Patent AU-2021231783-A1 (AU)
Title: A rodent model of B4GALT1-mediated functions
Inventor: GATTA GIUSY DELLA
IPC: A01K67/027
Filed: 2021-03-03
Abstract: This disclosure relates to genetically modified animals. More specifically, this disclosure relates to rodent animals in which an endogenous B4galt1 gene has been modified, e.g., to introduce a mutation that encodes an Asn to Ser substitution in the encoded B4galt1 protein at a position corresponding to position 352 in a human B4GALT1 protein, or to introduce a loss of function mutation (e.g., in a select tissue such as the liver). This disclosure also relates to use of such rodent animals in elucidating the role of B4galt1 in lipid metabolism.
Patent AU-2021242712-A1 (AU)
Title: Fiber and fiber manufacturing method
Inventor: FUKAZAWA HIROSHI
IPC: D01F9/08
Filed: 2021-03-18
Abstract: The purpose of the present invention is to provide a fiber and a fiber manufacturing method that can more effectively utilize waste discharged from an integrated coal gasification combined cycle.
　The fiber includes, as a material, waste discharged from an integrated coal gasification combined cycle (IGCC).
Patent AU-2021244135-A1 (AU)
Title: Method and system for extending push-to-talk service from land mobile radio systems to broadband systems
Inventor: MCDONALD DANIEL J
IPC: H04W4/10
Filed: 2021-03-11
Abstract: A method and system for processing a Push To Talk (PTT) call at an alternate bearer gateway. The alternate bearer gateway is connected to a Land Mobile Radio (LMR) Core Network and a Broadband Network. The alternate bearer gateway receives a PTT message from either the LMR Core Network or the Broadband Network. The PTT message includes a talkgroup identifier and a message. When the PTT message is received from the LMR Core Network, the alternate bearer network determines at least one Broadband talkgroup member using the talkgroup identifier. The alternate bearer gateway sends the message to the Broadband talkgroup member via the Broadband Network. When the PTT message is received from the Broadband Network, the alternate bearer gateway sends the message to the LMR Core Network.
Patent AU-2021256083-A1 (AU)
Title: Methods of diagnosing and treating viral infections
Inventor: ALMISHARI IBRAHIM SAUD
IPC: A61H33/00
Filed: 2021-04-13
Abstract: Diagnosing and treating viral infections. One example is a method of diagnosing absence of severe acute respiratory syndrome 2 (SARS-CoV-2), the method including: isolating a human in a covid-free environment for an isolation period; performing measurements of a core temperature during the isolation period; and if each of the measurements of the core temperature indicate a lack of fever, declaring the human free of SARS-CoV-2. Another example is a method including treating coronavirus in a human by: receiving a core temperature measurement; receiving a test result regarding the SARS-CoV-2 virus; responsive to the human having both fever and the presence of the SARS-CoV-2 virus, submerging the trunk and the legs of the human in water with a surfactant, and the human at least partially submerged for a treatment period of at least three hours; and controlling a temperature of the water during the treatment period.
Patent AU-2021262482-A1 (AU)
Title: Bicyclic kinase inhibitors and uses thereof
Inventor: SENNHENN PETER
IPC: A61K31/529
Filed: 2021-04-28
Abstract: The invention relates to kinase inhibitors, in particular inhibitors of protein kinases including the SIK-family, CSF1R, HCK, TEK-family, BRK, ABL, KIT and/or their mutants. Although structurally similar to other bicyclic kinase inhibitors, the kinase inhibitors of the invention are distinctive; possessing a particular class of heterocyclic moiety. Such kinase inhibitors can display one or more certain properties distinct to their structurally similar kinase inhibitors. The kinase inhibitors of the invention or pharmaceutical compositions comprising them may be used in the treatment of a disorder or condition, such as a proliferative disorder, for example, a leukaemia or solid tumour. In particular, these and other structurally related kinase inhibitors may be used in the treatment of a proliferative disorder - such as a mixed phenotype acute leukaemia (MPAL) - characterised by (inter-alia) the presence of MEF2C protein, a human chromosomal translocation at 11q23, and/or a KMT2A fusion oncoprotein. The kinase inhibitors or pharmaceutical compositions of the invention may be used topically to modulate skin pigmentation in a subject, for example to impart UV protection and reduce skin cancer risk.
Patent AU-2021269223-A1 (AU)
Title: Salts of neuroceuticals and uses thereof
Inventor: TSAI GUOCHUAN EMIL
IPC: C07D487/04
Filed: 2021-05-05
Abstract: A salt of a neuroceutical and of an acid, wherein the neuroceutical is a substituted benzodiazepine, a substituted benzothiazepine, a substituted pyridopyrimidines or a substituted amino-cyclohexaneacetic acid; and the acid is benzoic acid, nicotinic acid, pantothenic acid and tannic acid. The molar ratio of the neuroceutical and the acid in the salt ranges from about 6:1 to about 1:5. Also disclosed herein are compositions comprising the neuroceutical salt and therapeutic uses thereof for treating a central nervous system (CNS) disorder or a metabolic disorder associated with the CNS disorder.
Patent AU-2021277764-A1 (AU)
Title: Antibodies for treatment of cancer expressing claudin 6
Inventor: SAHIN UGUR
IPC: A61K39/395
Filed: 2021-12-03
Abstract: The present invention provides antibodies useful as therapeutics for treating and/or 
preventing diseases associated with cells expressing CLDN6, including tumor-related 
diseases such as ovarian cancer, lung cancer, gastric cancer, breast cancer, hepatic cancer, 
pancreatic cancer, skin cancer, malignant melanoma, head and neck cancer, carcinoma, bile 
duct cancer, cancer of the urinary bladder, kidney cancer, colon cancer, placental 
choriocarcinoma, cervical cancer, testicular cancer, and uterine cancer.
Patent AU-2021280361-A1 (AU)
Title: Biarylsulfonamides and pharmaceutical compositions thereof, and their use for treating fibrotic lung disease
Inventor: SWINDLEHURST CATHY A
IPC: C07C311/21
Filed: 2021-05-31
Abstract: Provided herein are a biarylsulfonamide, e.g., a compound of Formula (IA), and a pharmaceutical composition thereof. Also provided herein is a method of treating a fibrotic lung disease with a biarylsulfonamide, alone or in combination with an antifibrotic agent. Additionally, provided herein is a method of slowing the rate of decline in pulmonary function in a subject having a fibrotic lung disease with a biarylsulfonamide, alone or in combination with an antifibrotic agent.
Patent AU-2021283201-A1 (AU)
Title: Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use
Inventor: WEIDANZ JON
IPC: A61K47/68
Filed: 2021-06-01
Abstract: Provided herein are antibodies that selectively bind to complex comprising a non-classical HLA-I (e.g. HLA-E) and a neoantigen having variable heavy chain domains (VH), variable light chain domains (VL), and complementarity determining regions (CDRs) as disclosed herein, as well as methods and uses thereof.
Patent AU-2021286250-A1 (AU)
Title: Multiplex detection of vulvovaginal candidiasis, trichomoniasis and bacterial vaginosis
Inventor: PAQUETTE NANCY
IPC: C12Q1/68
Filed: 2021-12-13
Abstract: OF THE DISCLOSURE 
Methods and compositions for detection of vulvovaginal candidiasis (VVC), 
trichomoniasis and bacterial vaginosis (BV) are disclosed herein. In some embodiments, the 
presence or absence of VVC-associated Candida, Trichomonas valginalis, and a plurality of 
BV-related bacteria in a sample is determined using multiplex nucleic acid-based testing 
methods.
Patent AU-2021286449-A1 (AU)
Title: System and method for consolidating items for fulfilment of order in warehouse
Inventor: MOHAN SAI KRISHNA K V N B
IPC: B07C5/34
Filed: 2021-12-17
Abstract: A system and method for managing items for fulfilment of an order in a warehouse 
are provided. The method comprises retrieving, at one instance, at least one item of the one 
or more items associated with an order being processed; scanning the items to generate a 
scan information therefor; assigning one of storage bins of a plurality of storage bins to the 
order being processed based on the acquired scan information; one of one or more sorting 
robots, provided on one or more platform levels to collect the said at least one item and 
transfer the said at least one item to the assigned storage bin to the order being processed; 
and transferring the said assigned storage bin to a packaging station in the warehouse, when 
each of the one or more items associated with the order being processed are transferred to 
the said assigned storage bin.  
FIG. 4 
47
4/11 
00 
C 
CDN 
I- s 
I F - - I -------- ---V 
cc c 
,I t 1ItA aIV oc 
0)F 
VD
Patent AU-2021289062-A1 (AU)
Title: Method of preparing an aerated batter, the batter, a cake, use of protein in aerated batter, a powder composition and method of preparation
Inventor: NYTOFT RIKKE ELEONORE
IPC: A21D13/80
Filed: 2021-06-11
Abstract: The present invention relates to a method of preparing an aerated batter, the aerated batter prepared by the method, a cake obtainable by baking the aerated batter, the use of a protein source comprising beta-lactoglobulin in an aerated batter, a powder composition comprising the protein source comprising BLG and a method of producing the powder composition.
Patent AU-2021296364-A1 (AU)
Title: Human cytomegalovirus gB polypeptide
Inventor: CHI XIAOYUAN SHERRY
IPC: C07K14/045
Filed: 2021-06-18
Abstract: The present invention relates to polypeptides and cytomegalovirus (CMV) antigens that include at least two introduced amino acid mutations relative to the amino acid sequence of the wild-type HCMV glycoprotein B (gB). In some embodiments, the polypeptide is stabilized in a conformation alternative to the gB postfusion conformation. Also disclosed are compositions including the polypeptides and uses thereof.
Patent AU-2021325431-A1 (AU)
Title: Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
Inventor: BUSHABOINA MALLESH
IPC: A61P11/06
Filed: 2021-08-12
Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; (I) wherein R
Patent AU-2021348256-A1 (AU)
Title: Filter material for soil filters for phosphate adsorption
Inventor: BRUNS STEFAN
IPC: C04B28/06
Filed: 2021-09-28
Abstract: The present invention relates to a synthetic filter material, which consists of stone chips, one or more oxides or hydroxides of Fe, La, and/or Al, cement, a rapid-hardening agent and water, and can be used as a filter material for soil filters for adsorbing phosphate, and to a process for producing the filter material.
Patent AU-2021353861-A1 (AU)
Title: Carrier for containers
Inventor: MCCREE JUSTIN
IPC: B65D73/00
Filed: 2021-09-28
Abstract: A carrier for holding a plurality of containers includes a top panel having a plurality of container retention openings for at least partially receiving a respective container of the plurality of containers, at least one container retention flap foldably connected to the top panel at a fold line, and at least one reinforcement panel interrupting the fold line and positioned between the top panel and the at least one container retention flap.
Patent AU-2021359092-A1 (AU)
Title: Binding molecules that multimerise cd45
Inventor: RAPECKI STEPHEN EDWARD
IPC: A61P35/00
Filed: 2021-10-14
Abstract: The present invention provides binding molecule or molecules that are able to multimerise CD45 to induce cell death of a cell expressing CD45 without also inducing significant cytokine release. For example, the invention provides antibodies against CD45, wherein the antibodies comprise at least two different paratopes each specific for a different epitope of CD45. The antibodies may be used to cross-link CD45 on the surface of cells. The antibodies may be used in a variety of therapeutic ways including to deplete cells, for example prior to cell transplantation.
Patent AU-2021378903-A1 (AU)
Title: Novel use of bifidobacterium lactis bl-99 in fighting aging and improving innate immunity
Inventor: LIU WEI-HSIEN
IPC: C12N1/20
Filed: 2021-07-13
Abstract: A novel use of bifidobacterium lactis BL-99 in fighting aging and improving innate immunity. The present Bifidobacterium lactis, accession number CGMCC No. 15650, features such effects as fighting aging, increasing innate immunity in an organism, and raising the ability of an organism to defend against Staphylococcus aureus infection, thereby providing a use of Bifidobacterium lactics in preparing a composition having the effects of fighting aging, being able to increase innate immunity in an organism, and/or raising the ability of an organism to defend against Staphylococcus aureus infection.
Patent AU-2021383424-A1 (AU)
Title: Administration of sting agonist, checkpoint inhibitors, and radiation
Inventor: SHAW MICHAEL H
IPC: A61N5/10
Filed: 2021-11-18
Abstract: The present disclosure provides methods, pharmaceutical compositions, and kits for treating cancer in patients in need thereof. The methods comprise administering to a patient in need a STING (stimulator of interferon genes) agonist, such as Compound No. 14 as defined in the description, or a pharmaceutically acceptable salt thereof, in combination with one or more checkpoint inhibitors and radiation. Also provided are medicaments for use in treating cancer.
Patent AU-2021386369-A1 (AU)
Title: Assessment of mutation burden in skin
Inventor: DOBAK III JOHN DANIEL
IPC: C12Q1/6886
Filed: 2021-11-23
Abstract: Disclosed herein is a method of quantifying mutation burden of skin based on genomic mutations. In some instances, also described herein are methods of reducing skin cancer risk, such as that caused by UV damage or other environmental factor.